The YAP1 gene (YAP1 stands for: Yes1 Associated Transcriptional Regulator) is a protein-coding gene located on chromosome 11q22.1. Alternative splicing leads to several transcript variants encoding different isoforms. An important paralog of this gene is WWTR1.
YAP1 gene
DefinitionThis section has been translated automatically.
General informationThis section has been translated automatically.
The YAP1 gene encodes a downstream nuclear effector of the Hippo signaling pathway, which is involved in development, growth, repair and homeostasis. As a transcriptional regulator of this pathway, the YAP1 gene plays a role in the development and progression of various types of cancer and could serve as a potential target for cancer treatment.
PathophysiologyThis section has been translated automatically.
The encoded protein is not a transcriptional regulator with a dual function as coactivator and co-repressor. It is critical for organ size control and tumor suppression by limiting proliferation and promoting apoptosis. The core of the Hippo signaling pathway comprises a kinase cascade with STK3/MST2 and STK4/MST1 and its regulatory partner SAV1, which phosphorylates and activates LATS1/2 in conjunction with its regulatory protein MOB1. This activation leads to phosphorylation and inactivation of the oncoprotein YAP1 and WWTR1/TAZ (Zhao B et al. 2008). Phosphorylation of YAP1 by LATS1/2 prevents its translocation into the nucleus and thus regulates the expression of its target genes (Zhao B et al. 2008). Transcriptional regulation of gene expression requires TEAD transcription factors and modulates cell growth, anchorage-independent growth and induction of epithelial-mesenchymal transition (EMT) ((Zhao B et al. 2008).
Plays a key role in tissue tension and 3D tissue structure by regulating the cortical actomyosin network and acting via ARHGAP18, a Rho GTPase-activating protein that suppresses F-actin polymerization (Porazinski S et al. 2015). It also suppresses ciliogenesis by acting as a transcriptional co-repressor of the TEAD4 target genes AURKA and PLK1.
ClinicThis section has been translated automatically.
Diseases associated with YAP1 include coloboma, ocular, with or without hearing impairment, cleft lip/palate and/or impaired mental development and uveal coloboma, cleft lip/palate and mental retardation. Associated signaling pathways include gene expression (transcription) and endothelial cell response to shear stress.
LiteratureThis section has been translated automatically.
- Porazinski S et al. (2015) YAP is essential for tissue tension to ensure vertebrate 3D body shape. Nature 521:217-221.
- Rötzer V et al. (2016) Desmoglein 3-Dependent Signaling Regulates Keratinocyte Migration and Wound Healing. J Invest Dermatol 136:301-310.
- Tsang SM et al. (2012) Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris. J Pathol 227:81-93.
- Uttagomol J et al. (2019) Evidence for the Desmosomal Cadherin Desmoglein-3 in Regulating YAP and Phospho-YAP in Keratinocyte Responses to Mechanical Forces. Int J Mol Sci 20:6221.
- Zhao B et al. (2008) TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22:1962-1971